Nasopharyngeal Carcinoma Latest Advances
Find the Latest Research About Nasopharyngeal Carcinoma
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25702 publications
Corrigendum to "Effect of statins on the mortality of long-term survivors of nasopharyngeal carcinoma: population-based Study in endemic area" [The Lancet Regional Health-Western Pacific Volume 75 (2026) 101993].
Journal: The Lancet regional health. Western Pacific
Published: October 30, 2026
Benmelstobart With or Without Anlotinib After Chemoradiotherapy for Unresectable Non-Small Cell Lung Cancer: The R-ALPS Randomized Clinical Trial.
Journal: JAMA oncology
Published: October 29, 2026
Author Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial.
Journal: Nature medicine
Published: October 28, 2026
Meta-analysis of 990 EBV genomes identifies EBER2 SNP7048 and its interaction with HLA-A*11:01 driving nasopharyngeal carcinoma risk.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 20, 2026
Prior internal carotid artery embolization to optimize oncological and surgical outcomes in salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma.
Journal: Rhinology
Published: October 14, 2026
Correction: Autophagy hub genes mediate photodynamic therapy tolerance in nasopharyngeal carcinoma through cytoprotective autophagy and survival signalling.
Journal: Journal of molecular histology
Published: October 13, 2026
Development and validation of a metabolic syndrome-based nomogram to predict 1-year metastasis after radiotherapy in locally advanced nasopharyngeal carcinoma.
Journal: Annals of medicine
Published: October 12, 2026
Myelin oligodendrocyte glycoprotein antibody-associated disease in a patient with AIRE gene dominant-negative mutation.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 08, 2026
Radiologic Evaluation of the Nasopharynx: A Comprehensive Review.
Journal: Radiographics : a review publication of the Radiological Society of North America, Inc
Published: October 08, 2026
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; tovorafenib and dordaviprone for glioma, mirvetuximab soravtansine and pembrolizumab for ovarian cancer, tislelizumab for nasopharyngeal cancer, trastuzumab deruxtecan, palbociclib and datopotamab deruxtecan for breast cancer, epcoritamab for lymphoma, teclistamab for multiple myeloma.
Journal: International journal of clinical oncology
Published: October 03, 2026
Identification of glycoproteins as candidate biomarkers for nasopharyngeal carcinoma using Fe3O4@PDA@MOF-IDA and mM-TiO2@Cys enrichment and HPLC-MS proteomic analysis.
Journal: Analytical methods : advancing methods and applications
Published: October 02, 2026
Last Updated: 11/08/2026